Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | BMY | AMGN | GILD | VRTX |
| Company | Reata Pharma | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 172.34 | 57.66 | 264.04 | 73.21 | 345.28 |
| High | 172.46 | 58.05 | 266.03 | 73.87 | 347.79 |
| Low | 172.32 | 57.12 | 259.67 | 72.87 | 341.85 |
| Last | 172.36 | 57.35 | 261.54 | 73.40 | 343.92 |
| Change | +0.04 | -0.50 | -4.77 | -0.70 | -3.91 |
| % Change | +0.02% | -0.86% | -1.79% | -0.94% | -1.12% |
| Volume | 1,988,500 | 4,022,991 | 936,314 | 1,913,484 | 215,956 |
| 20-Day Average Volume | 810,510 | 11,455,765 | 2,334,329 | 5,053,311 | 872,139 |
| Previous Close | 172.32 | 57.85 | 266.31 | 74.10 | 347.83 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 59.03 | 263.61 | 75.47 | 348.98 |
| 20-Day Raw Stochastic | 97.36% | 2.79% | 47.05% | 5.66% | 11.06% |
| 20-Day Relative Strength | 81.56% | 33.36% | 51.19% | 37.09% | 44.10% |
| Weighted Alpha | +177.60 | -21.87 | +13.25 | +3.17 | +14.69 |
| Today's Opinion | 100% Buy | 100% Sell | 64% Buy | 100% Sell | 24% Buy |
| Previous Opinion | 100% Buy | 100% Sell | 88% Buy | 100% Sell | 48% Buy |
| Last Month's Opinion | 100% Buy | 80% Sell | 56% Buy | 80% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | -2.22% since 09/26/23 | -3.27% since 09/26/23 | -3.16% since 09/26/23 | -2.53% since 09/26/23 |
| Low | 171.96 on 09/19/23 | 57.12 on 10/03/23 | 259.67 on 10/03/23 | 72.87 on 10/03/23 | 341.89 on 10/03/23 |
| High | 172.46 on 09/25/23 | 58.75 on 09/27/23 | 273.61 on 09/27/23 | 76.06 on 09/27/23 | 354.52 on 09/28/23 |
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | -7.71% since 09/01/23 | +1.38% since 09/01/23 | -4.57% since 09/01/23 | -2.37% since 09/01/23 |
| Low | 168.67 on 09/05/23 | 57.12 on 10/03/23 | 248.38 on 09/06/23 | 72.87 on 10/03/23 | 340.83 on 09/06/23 |
| High | 172.46 on 09/25/23 | 62.00 on 09/05/23 | 273.61 on 09/27/23 | 77.73 on 09/14/23 | 358.59 on 09/20/23 |
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | -11.16% since 07/03/23 | +15.66% since 07/03/23 | -4.65% since 07/03/23 | -1.37% since 07/03/23 |
| Low | 88.80 on 06/27/23 | 57.12 on 10/03/23 | 218.44 on 07/07/23 | 72.87 on 10/03/23 | 335.82 on 07/07/23 |
| High | 172.46 on 09/25/23 | 65.38 on 07/24/23 | 273.61 on 09/27/23 | 81.43 on 08/09/23 | 367.00 on 07/21/23 |
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | -17.86% since 04/03/23 | +6.47% since 04/03/23 | -12.13% since 04/03/23 | +8.37% since 04/03/23 |
| Low | 76.54 on 05/10/23 | 57.12 on 10/03/23 | 211.71 on 06/01/23 | 72.87 on 10/03/23 | 313.47 on 04/04/23 |
| High | 172.46 on 09/25/23 | 71.07 on 04/06/23 | 273.61 on 09/27/23 | 87.37 on 04/24/23 | 367.00 on 07/21/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 120,854,608 | 142,449,472 | 92,329,640 | 89,773,184 |
| Shares Outstanding, K | 38,150 | 2,089,103 | 534,901 | 1,246,014 | 258,095 |
| Annual Sales | 2,220,000 | 46,159,000,000 | 26,323,000,000 | 27,281,000,000 | 8,930,700,000 |
| Annual Net Income | -311,900,000 | 6,327,000,000 | 6,552,000,000 | 4,592,000,000 | 3,322,000,000 |
| Last Quarter Sales | 22,750,000 | 11,226,000,000 | 6,986,000,000 | 6,599,000,000 | 2,493,200,000 |
| Last Quarter Net Income | 193,000,000 | 2,073,000,000 | 1,379,000,000 | 1,045,000,000 | 915,700,000 |
| 60-Month Beta | 1.42 | 0.43 | 0.59 | 0.37 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 1.75 on 07/27/23 | 5.00 on 08/03/23 | 1.34 on 08/03/23 | 3.89 on 08/01/23 |
| Latest Earnings Date | 11/14/23 | 10/26/23 | 11/02/23 | 10/26/23 | 10/26/23 |
| Most Recent Dividend | N/A | 0.570 on 07/06/23 | 2.130 on 08/17/23 | 0.750 on 09/14/23 | N/A |
| Next Ex-Dividends Date | N/A | 10/05/23 | 08/17/23 | 09/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 7.63 | 15.12 | 11.93 | 26.44 |
